Table 1.
Demographic and clinical characteristics of the study patients as stratified to CKD stages
| eGFR (ml/min/1.73 m 2 ) | ≥90 | 60-89 | 30-59 | 15-29 | <15 |
|---|---|---|---|---|---|
| Stage 1 | Stage 2 | Stage 3 | Stage 4 | Stage 5 | |
| (n = 39) | (n = 40) | (n = 39) | (n = 37) | (n = 42) | |
| Age (years) | 52 (30–73) | 55 (32–71) | 53 (31–73) | 56 (33–73) | 51 (30–73) |
| Sex (M/F) | 20/19 | 19/21 | 19/20 | 20/17 | 21/21 |
| BMI (kg/m 2 ) | 26.4 ± 2.3 | 26.8 ± 3.3 | 25.6 ± 2.8 | 26.2 ± 2.9 | 25.2 ± 2.6 |
| History of CVD (n) | |||||
| Fatal and nonfatal MI, acute coronary syndrome | 5 | 6 | 8 | 10 | 7 |
| Stroke | 0 | - | 3 | - | 1 |
| Peripheral vascular disease | 1 | 1 | 1 | 2 | 1 |
| Aortic aneurysm | - | - | - | - | 1 |
| Etiology of CKD (n) | |||||
| Diabetes | 6 | 10 | 7 | 12 | 8 |
| Glomerulonephritis | 6 | 7 | 7 | 5 | 6 |
| Hypertension | 5 | 8 | 7 | 6 | 7 |
| Polycystic kidney disease | 2 | 2 | 3 | 3 | 2 |
| Reflux Nephropathy | 2 | 1 | 2 | 1 | 2 |
| Unknown | 18 | 12 | 13 | 10 | 17 |
| Smoking, current or former (n) | 22 | 13 | 14 | 21 | 17 |
| CV events (n) | 7 | 10 | 8 | 13 | 16 |